Related Experiment Videos
Malignant melanomas contain only the vimentin type of intermediate filaments
Abstract:
Six malignant melanomas have been examined for the type of intermediate filament they contain. All six cases showed positive staining of intermediate filaments with antibodies to vimentin, with cells containing large numbers of melanosomes being stained less strongly in general. The tumor cells did not react with antibodies to keratin, desmin, neurofilaments or glial fibrillary acidic protein. Thus typing of intermediate filaments can distinguish melanoma from undifferentiated carcinoma, but not from lymphoma or sarcoma. Since melanocytes are known to be vimentin positive, and since most of the samples we studied were from metastases, these results are a further indication that the intermediate filament type typical of the parental cell is retained in the metastases, as well as in the primaries of solid tumours. The implications of vimentin positivity for the histiogenesis of the melanocyte are also discussed.
Insights
Malignant melanomas consistently express vimentin intermediate filaments. This finding aids in distinguishing melanoma from other cancers and suggests intermediate filament type is retained in metastases.
Area of Science:
- Oncology
- Cell Biology
- Immunohistochemistry
Background:
- Intermediate filaments are crucial cytoskeletal components.
- Melanoma diagnosis can be challenging, necessitating reliable biomarkers.
- Vimentin is a common intermediate filament protein found in various cell types.
Purpose of the Study:
- To investigate the expression of intermediate filaments in malignant melanoma.
- To determine if intermediate filament typing can aid in melanoma diagnosis and classification.
- To explore the implications of vimentin expression in melanoma cells and metastases.
Main Methods:
- Immunohistochemical staining of six malignant melanoma samples.
- Utilized antibodies specific to vimentin, keratin, desmin, neurofilaments, and glial fibrillary acidic protein.
- Correlated intermediate filament expression with melanosome presence and tumor origin (primary vs. metastasis).
Main Results:
- All six malignant melanoma cases exhibited positive vimentin intermediate filament staining.
- Tumor cells did not react with antibodies for keratin, desmin, neurofilaments, or glial fibrillary acidic protein.
- Vimentin positivity was observed in both primary and metastatic melanoma samples.
Conclusions:
- Vimentin intermediate filament expression is a characteristic feature of malignant melanoma.
- Intermediate filament typing can help differentiate melanoma from undifferentiated carcinomas.
- The retention of vimentin in metastases supports the concept of stable intermediate filament expression from parental cells.